The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Open accessAbstract
The GBA gene encodes for the lysosomal enzyme glucocerebrosidase (GCase), which maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have mutations in the GBA gene, making it numerically the most important genetic risk factor for Parkinson disease (PD). Clinically, GBA-associated PD is identical to sporadic PD, aside from the earlier age at onset (AAO), more frequent cognitive impairment and more rapid progression. Mutations in GBA can be associated with loss- and gain-of-function mechanisms. A key hallmark of PD is the presence of intraneuronal proteinaceous inclusions named Lewy bodies, which are made up primarily of alpha-synuclein. Mutations in the GBA gene may lead to loss of GCase activity and lysosomal dysfunction, which may impair alpha-synuclein metabolism. Models of GCase deficiency demonstrate dysfunction of the autophagic-lysosomal pathway and subsequent accumulation of alpha-synuclein. This dysfunction can also lead to aberrant lipid metabolism, including the accumulation of glycosphingolipids, glucosylceramide and glucosylsphingosine. Certain mutations cause GCase to be misfolded and retained in the endoplasmic reticulum (ER), activating stress responses including the unfolded protein response (UPR), which may contribute to neurodegeneration. In addition to these mechanisms, a GCase deficiency has also been associated with mitochondrial dysfunction and neuroinflammation, which have been implicated in the pathogenesis of PD. This review discusses the pathways associated with GBA-PD and highlights potential treatments which may act to target GCase and prevent neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–221 of 221
Glajch, K. E., Moors, T. E., Chen, Y., Bechade, P. A., Nam, A. Y., Rajsombath, M. M., McCaffery, T. D., Dettmer, U., Weihofen, A., Hirst, W. D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103425118 · Cited by 44
Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity
Ysselstein, D., Young, T. J., Nguyen, M. N., Padmanabhan, S., Hirst, W. D., Dzamko, N. L., & Krainc, D. (2021) · Movement Disorders · doi:10.1002/mds.28815 · Cited by 42
Khair, S. B. A., Dhanushkodi, N. R., Ardah, M. T., Chen, W., Yang, Y., & Haque, M. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00081 · Cited by 41
Phenotype in patients with Gaucher disease and Parkinson disease
Chetrit, E. B., Alcalay, R. N., Steiner‐Birmanns, B., Altarescu, G., Phillips, M., Elstein, D., & Zimran, A. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.11.011 · Cited by 40
Zhang, Y., Sun, Q., Zhao, Y., Li, S., Guo, J., Xu, Q., Yan, X., & Tang, B. (2015) · Parkinson s Disease · doi:10.1155/2015/916971 · Cited by 39
Sucunza, D., Rico, A. J., Roda, E., Collantes, M., González‐Aseguinolaza, G., Rodriguez-Perez, A. I., Peñuelas, I., Vázquez, A., Labandeira-García, J. L., Broccoli, V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094825 · Cited by 39
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
Alcalay, R. N., Wolf, P., Chiang, M. S. R., Helesicova, K., Zhang, X. K., Merchant, K., Hutten, S. J., Scherzer, C. R., Caspell‐Garcia, C., Blauwendraat, C., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51164 · Cited by 35
Chabás, A., Gort, L., Dı́az-Font, A., Montfort, M., Santamaría, R., Pidre, M. C., Grinberg, D., & Vilageliu, L. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.04.007 · Cited by 34
Yang, J., Hertz, E., Zhang, X., Leinartaité, L., Lundius, E. G., Li, J., & Svenningsson, P. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.023 · Cited by 33
The Association between E326K of GBA and the Risk of Parkinson’s Disease
Huang, Y., Deng, L., Zhong, Y., & Yi, M. (2018) · Parkinson s Disease · doi:10.1155/2018/1048084 · Cited by 32
Jewett, K. A., Thomas, R. E., Phan, C. Q., Lin, B. C., Milstein, G., Yu, S., Bettcher, L., Neto, F. C., Djukovic, D., Raftery, D., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1008859 · Cited by 31
UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease
Braunstein, H., Maor, G., Chicco, G., Filocamo, M., Zimran, A., & Horowitz, M. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.10.025 · Cited by 30
Cerri, S., Ghezzi, C., Ongari, G., Croce, S., Avenali, M., Zangaglia, R., Monte, D. A. D., Valente, E. M., & Blandini, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042215 · Cited by 30
Fu, A., Zhang, M., Gao, F., Xu, X., & Chen, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059642 · Cited by 28
Migdalska‐Richards, A., Węgrzynowicz, M., Harrison, I. F., Verona, G., Bellotti, V., Spillantini, M. G., & Schapira, A. H. V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238075 · Cited by 27
Self-citationGramlich, P. A., Westbroek, W., Feldman, R. A., Awad, O., Mello, N., Remington, M. P., Sun, Y., Zhang, W., Sidransky, E., Betenbaugh, M. J., et al. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.01.015 · Cited by 26
Is E326K glucocerebrosidase a polymorphic or pathological variant?
Liou, B., & Grabowski, G. A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.12.002 · Cited by 24
Higgins, A., Toffoli, M., Mullin, S., Lee, C., Koletsi, S., Avenali, M., Blandini, F., & Schapira, A. H. V. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2021-0032 · Cited by 13
Self-citationThe Cytotoxic Effect of α‐Synuclein Aggregates
Melo, F., Caballero, L., Zamorano, E., Ventura, N., Navarro, C., Doll, I., Zamorano, P. L., & Cornejo, A. (2021) · ChemPhysChem · doi:10.1002/cphc.202000831 · Cited by 9
Processing and maturation of human glucocerebrosidase
Bendikov-Bar, I., Maor, G., & Horowitz, M. (2013) · doi:10.2217/ebo.12.298 · Cited by 3
Glucocerebrosidase rescues alpha-synuclein from amyloid formationPreprint
Barber, M. S., Muller, H. M., Gilbert, R. J. C., & Baldwin, A. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/363986 · Cited by 2
Cited by
The pathogenesis of Parkinson's disease
Morris, H. R., Spillantini, M. G., Sue, C. M., & Williams-Gray, C. H. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01478-2 · Cited by 1,019
Metadata
- Authors
- Smith, L., & Schapira, A. H. V.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-04-08
- Volume
- 11
- Issue
- 8
- Pages
- 1261
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4224297855
- Cited by
- 256
- References
- 221
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.